Trove's switch from Hyperliquid to Solana has sparked discontent within the community, with supporters demanding refunds
Svmuu News: Trove Markets announced that, due to a liquidity partner withdrawing the 500,000 HYPE tokens required for the Hyperliquid integration, the project has decided to shift its development focus from Hyperliquid to the Solana network. Trove Markets had raised over $11.5 million through a token sale, which was originally intended for the Hyperliquid integration. The decision has drawn criticism from the community, with some supporters demanding immediate refunds. Unwise, a developer at Trove Markets, stated that the team will rebuild the DEX from scratch on Solana. The TROVE token generation event is still scheduled for Monday, but the migration and refund processing will require additional time. Additionally, ZachXBT has detected several suspicious transactions involving the transfer of HYPE tokens.
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
3
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
4
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
5
The analysis points out that Iran’s overlapping centers of power complicate efforts to end the war with the United States, and that the Revolutionary Guards possess significant operational autonomy.
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
8
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
9
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
10
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
Markets Today
Recommended Reading








